Early-onset autoimmunity associated with SOCS1 haploinsufficiency.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
21 10 2020
Historique:
received: 01 03 2020
accepted: 08 09 2020
entrez: 22 10 2020
pubmed: 23 10 2020
medline: 11 11 2020
Statut: epublish

Résumé

Autoimmunity can occur when a checkpoint of self-tolerance fails. The study of familial autoimmune diseases can reveal pathophysiological mechanisms involved in more common autoimmune diseases. Here, by whole-exome/genome sequencing we identify heterozygous, autosomal-dominant, germline loss-of-function mutations in the SOCS1 gene in ten patients from five unrelated families with early onset autoimmune manifestations. The intracellular protein SOCS1 is known to downregulate cytokine signaling by inhibiting the JAK-STAT pathway. Accordingly, patient-derived lymphocytes exhibit increased STAT activation in vitro in response to interferon-γ, IL-2 and IL-4 that is reverted by the JAK1/JAK2 inhibitor ruxolitinib. This effect is associated with a series of in vitro and in vivo immune abnormalities consistent with lymphocyte hyperactivity. Hence, SOCS1 haploinsufficiency causes a dominantly inherited predisposition to early onset autoimmune diseases related to cytokine hypersensitivity of immune cells.

Identifiants

pubmed: 33087723
doi: 10.1038/s41467-020-18925-4
pii: 10.1038/s41467-020-18925-4
pmc: PMC7578789
doi:

Substances chimiques

Cytokines 0
SOCS1 protein, human 0
STAT Transcription Factors 0
Suppressor of Cytokine Signaling 1 Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5341

Références

Nature. 2020 Jul;583(7814):90-95
pubmed: 32499645
Blood. 2007 Nov 1;110(9):3387-90
pubmed: 17652621
J Exp Med. 2011 Aug 1;208(8):1635-48
pubmed: 21727188
Nat Immunol. 2017 Mar 22;18(4):374-384
pubmed: 28323260
Nat Commun. 2018 Apr 19;9(1):1558
pubmed: 29674694
Blood. 2015 Jan 22;125(4):591-9
pubmed: 25359994
Blood. 2005 Mar 15;105(6):2535-42
pubmed: 15572583
J Allergy Clin Immunol. 2018 Dec;142(6):1932-1946
pubmed: 29729943
Nat Rev Immunol. 2007 Jun;7(6):454-65
pubmed: 17525754
Immunity. 2003 Sep;19(3):437-50
pubmed: 14499118
Trends Pharmacol Sci. 2019 May;40(5):298-308
pubmed: 30948191
J Exp Med. 2011 Sep 26;208(10):2055-67
pubmed: 21893603
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
J Allergy Clin Immunol. 2016 Jan;137(1):3-17
pubmed: 26768758
J Allergy Clin Immunol. 2018 Nov;142(5):1665-1669
pubmed: 30092289
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nat Methods. 2016 Feb;13(2):109-10
pubmed: 26820543
J Allergy Clin Immunol. 2018 Mar;141(3):1028-1035
pubmed: 28606585
Int Immunol. 2002 Nov;14(11):1343-50
pubmed: 12407025
Cell. 2007 Jul 13;130(1):25-35
pubmed: 17632054
Int Immunol. 2004 Feb;16(2):303-14
pubmed: 14734616
Blood. 2011 Nov 3;118(18):4798-807
pubmed: 21885602
Blood. 2015 Jan 22;125(4):639-48
pubmed: 25349174
Nat Genet. 2014 Aug;46(8):812-814
pubmed: 25038750
Cell. 1999 Sep 3;98(5):597-608
pubmed: 10490099
J Clin Invest. 2011 Jan;121(1):106-12
pubmed: 21183795
Front Immunol. 2017 Oct 16;8:1292
pubmed: 29085365
Nat Med. 2016 Jan;22(1):16-7
pubmed: 26735402
Science. 2014 Sep 26;345(6204):1623-1627
pubmed: 25213377
Genes Chromosomes Cancer. 2016 Mar;55(3):251-67
pubmed: 26608593
J Hematol Oncol. 2017 Mar 17;10(1):70
pubmed: 28302137
Blood. 2009 Nov 12;114(20):4503-6
pubmed: 19734449
J Immunol. 2017 Jul 1;199(1):149-158
pubmed: 28550203
Bioinformatics. 2018 Dec 15;34(24):4307-4309
pubmed: 30535305
N Engl J Med. 2011 Jul 7;365(1):54-61
pubmed: 21714643
Cell. 1999 Sep 3;98(5):609-16
pubmed: 10490100
Front Pharmacol. 2019 Apr 11;10:324
pubmed: 31105556
N Engl J Med. 2016 Mar 17;374(11):1032-1043
pubmed: 26981933
Blood. 1999 Oct 15;94(8):2575-82
pubmed: 10515860
Blood. 2005 Sep 1;106(5):1668-75
pubmed: 15899915

Auteurs

Jérôme Hadjadj (J)

Université de Paris, Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 24 boulevard du Montparnasse, 75015, Paris, France.
Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France.

Carla Noemi Castro (CN)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Maud Tusseau (M)

Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.

Marie-Claude Stolzenberg (MC)

Université de Paris, Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 24 boulevard du Montparnasse, 75015, Paris, France.
Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France.

Fabienne Mazerolles (F)

Université de Paris, Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 24 boulevard du Montparnasse, 75015, Paris, France.
Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France.

Nathalie Aladjidi (N)

Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE), CIC 1401, Inserm CICP, Bordeaux, France.
Pediatric Oncology Hematology Unit, University Hospital, place Amélie Raba Léon, CIC 1401, Inserm, CICP, Bordeaux, France.

Martin Armstrong (M)

Translational Medicine, UCB Pharma, Braine-l'Alleud, Belgium.

Houman Ashrafian (H)

Experimental Therapeutics, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.

Ioana Cutcutache (I)

Translational Medicine, UCB Pharma, Slough, United Kingdom.

Georg Ebetsberger-Dachs (G)

Department of Pediatrics, Kepler University Hospital and School of Medicine, Johannes Kepler University, Linz, Austria.

Katherine S Elliott (KS)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Isabelle Durieu (I)

Internal Medicine and Vascular Pathology Department, Adult Cystic Fibrosis Center, Groupement Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
EA 7425 HESPER. Université de Lyon, Lyon, France.

Nicole Fabien (N)

Immunology laboratory; Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.

Mathieu Fusaro (M)

Study Center for Primary Immunodeficiencies, AP-HP, Necker Hospital for Sick Children, Paris, France.

Maximilian Heeg (M)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Yohan Schmitt (Y)

Genomic Core Facility, INSERM UMR1163, Imagine Institute, Paris, France.

Marc Bras (M)

Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France.

Julian C Knight (JC)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Jean-Christophe Lega (JC)

Department of Internal and Vascular Medicine, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
National Referee Centre for Pediatric-Onset Rheumatism and Autoimmune Diseases (RAISE), Lyon, France.
UMR 5558, Equipe Evaluation et Modélisation des Effets Thérapeutiques, Laboratoire de Biométrie et Biologie Evolutive, CNRS, Claude Bernard University Lyon 1, Lyon, France.

Gaetan Lesca (G)

Service de Génétique, Hospices Civils de Lyon - GHE, and Institut Neuromyogène, CNRS UMR 5310 - INSERM U1217, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Anne-Laure Mathieu (AL)

Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.

Marion Moreews (M)

Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.

Baptiste Moreira (B)

Immunology Laboratory, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Audrey Nosbaum (A)

Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.
Allergy and Clinical Immunology department, Groupement Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.

Matthew Page (M)

Translational Medicine, UCB Pharma, Braine-l'Alleud, Belgium.

Cécile Picard (C)

Institut de Pathologie Multisite, Groupement Hospitalier Est, Hospices Civils de Lyon, UCBL Lyon 1 University, Lyon, France.

T Ronan Leahy (T)

Department of Paediatric Immunology and Infectious Diseases, Children's Health Ireland at Crumlin, Dublin, Ireland.

Isabelle Rouvet (I)

Centre de biotechnologie cellulaire et Biothèque, Groupe Hospitalier Est, Hospices Civils de Lyon, 69677, Bron, France.

Ethel Ryan (E)

Department of Paediatrics, University Hospital Galway, Co, Galway, Ireland.

Damien Sanlaville (D)

Service de Génétique, Hospices Civils de Lyon - GHE, and Institut Neuromyogène, CNRS UMR 5310 - INSERM U1217, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Klaus Schwarz (K)

Institute for Transfusion Medicin, University Ulm and Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Württemberg-Hessen, 89081, Ulm, Germany.

Andrew Skelton (A)

Translational Medicine, UCB Pharma, Slough, United Kingdom.

Jean-Francois Viallard (JF)

Département de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire Haut Lévêque, Université de Bordeaux, Pessac, France.

Sebastien Viel (S)

Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.
Service d'Immunologie Biologique, Groupement Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.

Marine Villard (M)

Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.

Isabelle Callebaut (I)

Sorbonne Université, Muséum National d'Histoire Naturelle, Centre National de la Recherche Scientifique Unité Mixte de Recherche 7590, Institut de Minéralogie, de Physique des Matériaux et de Cosmochimie, Paris, France.

Capucine Picard (C)

Study Center for Primary Immunodeficiencies, AP-HP, Necker Hospital for Sick Children, Paris, France.
Université de Paris, Imagine institute, laboratory of Iymphocyte activation and susceptibility to EBV, INSERM UMR 1163, 24 boulevard du Montparnasse, Paris, 75015, France.

Thierry Walzer (T)

Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.

Stephan Ehl (S)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.

Alain Fischer (A)

Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France.
Paediatric Immuno-Haematology and Rheumatology Department, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, 75015, Paris, France.
Collège de France, Paris, France.

Bénédicte Neven (B)

Université de Paris, Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 24 boulevard du Montparnasse, 75015, Paris, France.
Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France.
Paediatric Immuno-Haematology and Rheumatology Department, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, 75015, Paris, France.

Alexandre Belot (A)

Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France. alexandre.belot@chu-lyon.fr.
National Referee Centre for Pediatric-Onset Rheumatism and Autoimmune Diseases (RAISE), Lyon, France. alexandre.belot@chu-lyon.fr.
Hospices Civils de Lyon, Paediatric Nephrology, Rheumatology, Dermatology Unit, Mother and Children University Hospital, Bron, France. alexandre.belot@chu-lyon.fr.

Frédéric Rieux-Laucat (F)

Université de Paris, Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 24 boulevard du Montparnasse, 75015, Paris, France. frederic.rieux-laucat@inserm.fr.
Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France. frederic.rieux-laucat@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH